Last reviewed · How we verify
A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196
The study will evaluate one-way interaction of calcium carbonate, omeprazole, or rifampin on ACP-196.
Details
| Lead sponsor | Acerta Pharma BV |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 72 |
| Start date | Sun Sep 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Oct 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy Participants
Interventions
- ACP-196
- Calcium carbonate
- Omeprazole
- Rifampin
Countries
United States